White House report says Trump can usher in a "new golden age" of science

The White House has published a report titled "Science: A New Golden Age," and the document is best understood as a branding exercise rather than a policy blueprint. It positions itself as the heir to Vannevar Bush's 1945 "Science, the Endless Frontier," the memo that justified sustained federal research funding after the war. The lineage is deliberate. By invoking that legacy, the administration borrows the moral authority of a document that built the modern American research enterprise.

The problem is the contradiction at the center. The same administration has proposed deep cuts to research budgets and has moved to give political appointees the authority to terminate grants on ideological grounds. A report that ignores those facts while declaring a new golden age is not analysis. It is narrative management.

The content itself is a patchwork. Some sections echo concerns already circulating inside the scientific community, such as the slow pace of translational research and the friction in peer review. Other sections read as political grievance dressed in policy language. And running through it is a Silicon Valley sensibility, unsurprising given that OSTP director Michael Kratsios came directly from the orbit of Peter Thiel. The report treats commercialization not as one output of research but as its organizing principle.

That framing matters for anyone watching the labor market in science and technology. When federal funding contracts and grant termination becomes politicized, the talent that once flowed into academic and public-interest research does not disappear. It migrates toward private capital, where the agenda is set by investors rather than by peer-reviewed merit. The report's vision accelerates exactly that shift, even as it celebrates the idea of scientific independence.

The original "Endless Frontier" argued that basic research, funded without commercial pressure, was a public good worth defending. The new document inverts that logic. It assumes the market is the natural destination for scientific output and asks government to clear the path. Whether one agrees with that premise or not, the structural consequence is clear: the center of gravity in American science moves further from the public sector and closer to venture-backed priorities.

The report is unlikely to carry the weight of its predecessor. Bush's memo shaped decades of bipartisan consensus. This document, released without legislative backing and contradicted by the administration's own budget proposals, reads more like a manifesto than a foundation. Its real function may be to set the vocabulary for the next round of fights over what science is for, and who gets to decide.